title: Effect on liver tumor growth in rats of allopurinol and 5-fluorouracil in combination with hepatic artery ligation.
abstract: Rats with an experimental solitary liver tumor of a nitrosoguanidine-induced colonic adenocarcinoma were subjected to hepatic artery ligation (HAL) alone or in combination with 5-fluorouracil (5-FU) in three different doses, with or without the addition of allopurinol. The drugs were injected i.p. on 3 consecutive days before or after the HAL procedure. HAL alone significantly reduced the tumor growth compared with the control procedure (P less than 0.001). This observation was correlated with a significantly prolonged survival for the ligated animals (P less than 0.01). The administration of a low dose of 5-FU (15 mg/kg per day) in combination with allopurinol (100 mg/kg per day) enhanced tumor growth compared with that in animals treated with 5-FU only (P less than 0.01) or nontreated animals (P less than 0.05). A significant increase in survival was observed in animals given a high dose of 5-FU (60 mg/kg per day) after HAL compared with non-treated animals (P less than 0.001) as well as animals subjected to HAL alone (P less than 0.02). All animals receiving more than 15 mg/kg per day 5-FU before HAL succumbed within 10 days. The addition of allopurinol did not protect the animals against this mortality. These observations indicate that the effect of HAL followed by 5-FU is dose-dependent and that, at least in this treatment modality, allopurinol does not modulate the toxicity of 5-FU.
authors.affiliation: Department of Surgery, Ostra sjukhuset, Göteborg, Sweden.
authors.forename: G
authors.initials: G
authors.lastname: Carlsson
authors.forename: B
authors.initials: B
authors.lastname: Gustavsson
authors.forename: L
authors.initials: L
authors.lastname: Hafström
mesh_terms: D000493:Allopurinol / Q000008:administration & dosage* / Q000494:pharmacology; D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage* / Q000627:therapeutic use; D006499:Hepatic Artery; D008026:Ligation; D008114:Liver Neoplasms, Experimental / Q000098:blood supply / Q000401:mortality / Q000628:therapy*; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains
chemical_list: D000493:Allopurinol; D005472:Fluorouracil